BR0201973A - Azalide Antibiotic Compositions - Google Patents

Azalide Antibiotic Compositions

Info

Publication number
BR0201973A
BR0201973A BR0201973-6A BR0201973A BR0201973A BR 0201973 A BR0201973 A BR 0201973A BR 0201973 A BR0201973 A BR 0201973A BR 0201973 A BR0201973 A BR 0201973A
Authority
BR
Brazil
Prior art keywords
antibiotic compositions
azalide antibiotic
compositions
azalide
acids
Prior art date
Application number
BR0201973-6A
Other languages
Portuguese (pt)
Inventor
Wayne Alan Boettner
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0201973A publication Critical patent/BR0201973A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Aqueous antibiotic compositions comprising a mixture of an azalide compound, propylene glycol, and one or more acids, and methods for preparing such compositions, are disclosed. <IMAGE>
BR0201973-6A 2001-05-31 2002-05-28 Azalide Antibiotic Compositions BR0201973A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29467701P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
BR0201973A true BR0201973A (en) 2003-04-22

Family

ID=23134451

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0201973-6A BR0201973A (en) 2001-05-31 2002-05-28 Azalide Antibiotic Compositions

Country Status (12)

Country Link
US (1) US20030092640A1 (en)
EP (1) EP1262186B1 (en)
JP (1) JP2003040782A (en)
AT (1) ATE264684T1 (en)
BR (1) BR0201973A (en)
CA (1) CA2387821A1 (en)
DE (1) DE60200391T2 (en)
DK (1) DK1262186T3 (en)
ES (1) ES2218509T3 (en)
MX (1) MXPA02005381A (en)
PT (1) PT1262186E (en)
TR (1) TR200400954T4 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
JP2007277095A (en) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd Azithromycin-containing reversible heat-gellable aqueous composition
US8078327B2 (en) * 2006-04-04 2011-12-13 Union Plastic (Hangzhou) Machinery Co., Ltd. Control method of a hydraulic machine for saving energy or improving efficiency
EP2098219A1 (en) 2008-03-05 2009-09-09 PARI Pharma GmbH Macrolide compositions having improved taste and stability
CN102939106B (en) * 2010-02-24 2016-06-29 艾瑞克有限公司 Protein formulation
CN103965273B (en) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 A kind of macrolides compound
CN105669798B (en) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 A kind of macrolides compound
CN103690560B (en) * 2013-12-17 2016-08-17 辽宁海思科制药有限公司 A kind of Invert sugar electrolyte injection pharmaceutical composition and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000074A (en) * 1997-06-11 1999-01-08 Pfizer Prod Inc DERIVATIVES FROM MACROLIDES C-4 SUBSTITUTED
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
EP1250343B1 (en) * 2000-01-27 2003-06-25 Pfizer Products Inc. Azalide antibiotic compositions
WO2001081358A1 (en) * 2000-04-27 2001-11-01 Pfizer Products Inc. The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals

Also Published As

Publication number Publication date
MXPA02005381A (en) 2002-12-09
DE60200391D1 (en) 2004-05-27
TR200400954T4 (en) 2004-07-21
CA2387821A1 (en) 2002-11-30
DK1262186T3 (en) 2004-07-26
JP2003040782A (en) 2003-02-13
PT1262186E (en) 2004-06-30
EP1262186B1 (en) 2004-04-21
ATE264684T1 (en) 2004-05-15
DE60200391T2 (en) 2005-05-04
EP1262186A1 (en) 2002-12-04
ES2218509T3 (en) 2004-11-16
US20030092640A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
ATE243703T1 (en) ANTIBIOTIC AZALIDE COMPOSITIONS
BR0206155B1 (en) crystalline propylene copolymer compositions having improved optical and sealing properties and reduced solubility.
NO993996L (en) N-heterocyclic derivatives as NOS inhibitors
CY1107896T1 (en) Preparation of Lyophilized Pantoprazole and Injection of Pantoprazole
CY1108456T1 (en) BENZIMIDAZOLONE COMPOUNDS
CY1107331T1 (en) SOLID STEEL SOLUTION STANDARD STANDARDS
EP1420787B8 (en) Ophthalmic composition comprising an ascomycin
WO2001034647A3 (en) Animal collagens and gelatins
BR0201973A (en) Azalide Antibiotic Compositions
DK1434779T3 (en) Cross-linked glycopeptide-cephalosporin antibiotics
ES2186615T3 (en) NEW DERIVATIVES OF ERYTHROMYCIN, ITS PREPARATION PROCEDURE AND ITS APPLICATION AS MEDICATIONS.
ECSP034598A (en) LACTAMIC COMPOUND
EA199901056A1 (en) IMPROVED METHOD FOR OBTAINING ANTIPARASITIVE AGENT
DK1192139T3 (en) Preparation of Quinoline Substituted Carbonate and Carbamate Derivatives
DE60025494D1 (en) EPOTHILONE COMPOSITIONS
NO20030937D0 (en) Creatine-ester pronutrient compounds and formulations
ITMI20001695A0 (en) PROCEDURE FOR THE PREPARATION OF ORGANIC-SILICONIC COMPOSITIONS.
AU2002249863A1 (en) Stabilization of radiopharmaceutical compositions using hydrophilic thioether or a hydrophilic 6-hydroxy chroman
NO20014753D0 (en) C (10) carbonate substituted taxanes as antitumor agents
WO2003011266A3 (en) Azalide antibiotic compositions
NO20014755D0 (en) C (7) carbonate substituted taxanes as antitumor agents
PT1339703E (en) PROCESS FOR THE PREPARATION OF PACLITAXEL
WO2000040589A3 (en) Novel derivatives from the class of oleandomycin
ITMI992127A0 (en) PROCESS FOR THE PREPARATION OF AN ARYL-PYRIDINE COMPOUND
PL366546A1 (en) Sulfate of cephem compound

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.